目次

1. Executive Summary

2. Market Landscape
2.1 Market ecosystem
Exhibit 01: Parent market
2.2: Market Characteristics
Exhibit 02: Market Characteristics
2.2 Value chain analysis
Exhibit 03: Value chain analysis for pharmaceuticals
2.2.1 Research and development (R&D) and drug discovery
2.2.2 Integration and product development
2.2.3 Manufacturing
2.2.4 Outbound logistics
2.2.5 Marketing and sales
2.2.6 Support services
2.2.7 Innovation

3. Market Sizing
3.1 Market definition
Exhibit 04: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 05: Market segments
3.3 Market size 2020
3.4 Market outlook: Forecast for 2020 - 2025
Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 08: Five forces analysis 2020 & 2025
4.2 Bargaining power of buyers
Exhibit 09: Bargaining power of buyers
4.3 Bargaining power of suppliers
Exhibit 10: Bargaining power of suppliers
4.4 Threat of new entrants
Exhibit 11: Threat of new entrants
4.5 Threat of substitutes
Exhibit 12: Threat of substitutes
4.6 Threat of rivalry
Exhibit 13: Threat of rivalry
4.7 Market condition
Exhibit 14: Market condition - Five forces 2020

5. Market Segmentation by Distribution channel
5.1 Market segments
The segments covered in this chapter are:
o Retail
o Online
Exhibit 15: Distribution channel - Market share 2020-2025 (%)
5.2 Comparison by Distribution channel
Exhibit 16: Comparison by Distribution channel
5.3 Retail - Market size and forecast 2020-2025
Exhibit 17: Retail - Market size and forecast 2020-2025 ($ million)
Exhibit 18: Retail - Year-over-year growth 2020-2025 (%)
5.4 Online - Market size and forecast 2020-2025
Exhibit 19: Online - Market size and forecast 2020-2025 ($ million)
Exhibit 20: Online - Year-over-year growth 2020-2025 (%)
5.5 Market opportunity by Distribution channel
Exhibit 21: Market opportunity by Distribution channel

6. Customer landscape
6.1 Overview
Exhibit 22: Customer landscape

7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 23: Market share By Geographical Landscape 2020-2025 (%)
7.2 Geographic comparison
Exhibit 24: Geographic comparison
7.3 North America - Market size and forecast 2020-2025
Exhibit 25: North America - Market size and forecast 2020-2025 ($ million)
Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
7.4 Europe - Market size and forecast 2020-2025
Exhibit 27: Europe - Market size and forecast 2020-2025 ($ million)
Exhibit 28: Europe - Year-over-year growth 2020-2025 (%)
7.5 Asia - Market size and forecast 2020-2025
Exhibit 29: Asia - Market size and forecast 2020-2025 ($ million)
Exhibit 30: Asia - Year-over-year growth 2020-2025 (%)
7.6 ROW - Market size and forecast 2020-2025
Exhibit 31: ROW - Market size and forecast 2020-2025 ($ million)
Exhibit 32: ROW - Year-over-year growth 2020-2025 (%)
7.7 Key leading countries
Exhibit 33: Key leading countries
7.8 Market opportunity By Geographical Landscape
Exhibit 34: Market opportunity By Geographical Landscape ($ million)

8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Growing urban population
Exhibit 35: Urban population (% of the population), 2019
8.1.2 Increase in sales outlets
8.1.3 Increase in older adult population
Exhibit 36: Older population aged 65 years and above (% of the total population), 2019
8.2 Market challenges
8.2.1 Low penetration in developing regions
8.2.2 Stringent government regulations
8.2.3 Ignorance about health benefits of brain health supplements
Exhibit 37: Impact of drivers and challenges
8.3 Market trends
8.3.1 Growing demand in online retail
8.3.2 Increasing awareness through social media marketing
8.3.3 Monetary growth among consumers

9. Vendor Landscape
10.1 Competitive scenario
10.2 Vendor landscape
Exhibit 38: Vendor Landscape
10.3 Landscape disruption
Exhibit 39: Landscape disruption
10.4 Industry risks
Exhibit 40: Industry risks

11. Vendor Analysis
11.1 Vendors covered
Exhibit 41: Vendors covered
10.2 Market positioning of vendors
Exhibit 42: Market positioning of vendors
10.3 Abbott Laboratories
Exhibit 43: Abbott Laboratories - Overview
Exhibit 44: Abbott Laboratories - Business segments
Exhibit 45: Abbott Laboratories - Key news
Exhibit 46: Abbott Laboratories - Key offerings
Exhibit 47: Abbott Laboratories - Segment focus
10.4 Amway Corp.
Exhibit 48: Amway Corp. - Overview
Exhibit 49: Amway Corp. - Product and service
Exhibit 50: Amway Corp. â?“ Key news
Exhibit 51: Amway Corp. - Key offerings
10.5 Archer Daniels Midland Co.
Exhibit 52: Archer Daniels Midland Co. - Overview
Exhibit 53: Archer Daniels Midland Co. - Business segments
Exhibit 54: Archer Daniels Midland Co. â?“ Key news
Exhibit 55: Archer Daniels Midland Co. - Key offerings
Exhibit 56: Archer Daniels Midland Co. - Segment focus
10.6 Arkopharma Laboratories
Exhibit 57: Arkopharma Laboratories - Overview
Exhibit 58: Arkopharma Laboratories - Product and service
Exhibit 59: Arkopharma Laboratories - Key offerings
10.7 BASF SE
Exhibit 60: BASF SE - Overview
Exhibit 61: BASF SE - Business segments
Exhibit 62: BASF SE â?“ Key news
Exhibit 63: BASF SE - Key offerings
Exhibit 64: BASF SE - Segment focus
10.8 Bayer AG
Exhibit 65: Bayer AG - Overview
Exhibit 66: Bayer AG - Business segments
Exhibit 67: Bayer AG â?“ Key news
Exhibit 68: Bayer AG - Key offerings
Exhibit 69: Bayer AG - Segment focus
10.9 Glanbia Plc
Exhibit 70: Glanbia Plc - Overview
Exhibit 71: Glanbia Plc - Business segments
Exhibit 72: Glanbia Plc - Key offerings
Exhibit 73: Glanbia Plc - Segment focus
10.10 GNC Holdings Inc.
Exhibit 74: GNC Holdings Inc. - Overview
Exhibit 75: GNC Holdings Inc. - Business segments
Exhibit 76: GNC Holdings Inc. - Key offerings
Exhibit 77: GNC Holdings Inc. - Segment focus
10.11 Hi-Tech Pharmaceuticals Inc.
Exhibit 78: Hi-Tech Pharmaceuticals Inc. - Overview
Exhibit 79: Hi-Tech Pharmaceuticals Inc. - Product and service
Exhibit 80: Hi-Tech Pharmaceuticals Inc. - Key offerings
10.12 Koninklijke DSM NV
Exhibit 81: Koninklijke DSM NV - Overview
Exhibit 82: Koninklijke DSM NV - Business segments
Exhibit 83: Koninklijke DSM NV â?“ Key news
Exhibit 84: Koninklijke DSM NV - Key offerings

12. Appendix
12.1 Scope of the report
12.1.1 Market definition
12.1.2 Objectives
12.1.3 Notes and caveats
12.2 Currency conversion rates for US$
Exhibit 85: Currency conversion rates for US$
12.3 Research Methodology
Exhibit 86: Research Methodology
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: Information sources
12.4 List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Distribution channel - Market share 2020-2025 (%)
22: Comparison by Distribution channel
23: Retail - Market size and forecast 2020-2025 ($ million)
24: Retail - Year-over-year growth 2020-2025 (%)
25: Online - Market size and forecast 2020-2025 ($ million)
26: Online - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Distribution channel
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Abbott Laboratories - Overview
48: Abbott Laboratories - Business segments
49: Abbott Laboratories - Key offerings
50: Abbott Laboratories - Key customers
51: Abbott Laboratories - Segment focus
52: Amway Corp. - Overview
53: Amway Corp. - Product and service
54: Amway Corp. - Key offerings
55: Amway Corp. - Key customers
56: Amway Corp. - Segment focus
57: Archer Daniels Midland Co. - Overview
58: Archer Daniels Midland Co. - Business segments
59: Archer Daniels Midland Co. - Key offerings
60: Archer Daniels Midland Co. - Key customers
61: Archer Daniels Midland Co. - Segment focus
62: Arkopharma Laboratories - Overview
63: Arkopharma Laboratories - Product and service
64: Arkopharma Laboratories - Key offerings
65: Arkopharma Laboratories - Key customers
66: Arkopharma Laboratories - Segment focus
67: BASF SE - Overview
68: BASF SE - Business segments
69: BASF SE - Key offerings
70: BASF SE - Key customers
71: BASF SE - Segment focus
72: Bayer AG - Overview
73: Bayer AG - Business segments
74: Bayer AG - Key offerings
75: Bayer AG - Key customers
76: Bayer AG - Segment focus
77: Glanbia Plc - Overview
78: Glanbia Plc - Business segments
79: Glanbia Plc - Key offerings
80: Glanbia Plc - Key customers
81: Glanbia Plc - Segment focus
82: GNC Holdings Inc. - Overview
83: GNC Holdings Inc. - Business segments
84: GNC Holdings Inc. - Key offerings
85: GNC Holdings Inc. - Key customers
86: GNC Holdings Inc. - Segment focus
87: Hi-Tech Pharmaceuticals Inc. - Overview
88: Hi-Tech Pharmaceuticals Inc. - Product and service
89: Hi-Tech Pharmaceuticals Inc. - Key offerings
90: Hi-Tech Pharmaceuticals Inc. - Key customers
91: Hi-Tech Pharmaceuticals Inc. - Segment focus
92: Koninklijke DSM NV - Overview
93: Koninklijke DSM NV - Business segments
94: Koninklijke DSM NV - Key offerings
95: Koninklijke DSM NV - Key customers
96: Koninklijke DSM NV - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations